Format

Send to

Choose Destination
See comment in PubMed Commons below
Scand Cardiovasc J. 2008 Aug;42(4):256-63. doi: 10.1080/14017430802014838.

Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome.

Author information

  • 1Department of Biochemistry, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, New York 11203, USA. rfeinman@downstate.edu

Abstract

Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia. As such, the theory is intuitive and has substantial experimental support. It has generally been opposed by health agencies because of concern that carbohydrate will be replaced by fat, particularly saturated fat, thereby increasing the risk of cardiovascular disease as dictated by the so-called diet-heart hypothesis. Here we summarize recent data showing that, in fact, substitution of fat for carbohydrate generally improves cardiovascular risk factors. Removing the barrier of concern about dietary fat makes carbohydrate restriction a reasonable, if not the preferred method for treating type 2 diabetes and metabolic syndrome. We emphasize the ability of low carbohydrate diets to improve glycemic control, hemoglobin A1C and to reduce medication. We review evidence that such diets are effective even in the absence of weight loss.

PMID:
18609058
DOI:
10.1080/14017430802014838
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center